The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil: Findings and implications

Lays P. Marra, Vânia E. Araújo, Gerusa C.C. Oliveira, Leonardo M. Diniz, Augusto A. Guerra, Francisco De Assis Acurcio, Brian Godman*, Juliana Álvares

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Published studies have challenged the cost-effectiveness of insulin glargine versus neutral protamine hagedorn (NPH) insulins in Brazil with limited evidence of increased effectiveness despite considerably higher acquisition costs. However, still a controversy. Consequently, there is a need to address this. Materials & methods: Retrospective cohort study of Type I diabetes patients receiving insulin glargine in Brazil following NPH insulin who met the criteria.

Original languageEnglish
Pages (from-to)519-527
Number of pages9
JournalFuture Virology
Volume12
Issue number9
DOIs
Publication statusPublished - 2017

Keywords

  • Brazil
  • Comparative effectiveness research
  • Insulin glargine
  • Longitudinal studies
  • NPH insulin
  • Type I diabetes

Fingerprint

Dive into the research topics of 'The clinical effectiveness of insulin glargine in patients with Type i diabetes in Brazil: Findings and implications'. Together they form a unique fingerprint.

Cite this